Previous Article | Next Article 
Journal of Clinical Microbiology, August 1999, p. 2729-2733, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
An Uncommon Helicobacter Isolate from
Blood: Evidence of a Group of Helicobacter spp. Pathogenic
in AIDS Patients
Susan C.
Weir,1
Cynthia L.
Gibert,2
Fred M.
Gordin,2
Steven H.
Fischer,1 and
Vee J.
Gill1,*
Microbiology Service, Clinical Pathology
Department, National Institutes of Health, Bethesda, Maryland
20892,1 and Department of Infectious
Diseases, Veterans Affairs Medical Center, Washington, D.C.
204222
Received 16 December 1998/Returned for modification 7 February
1999/Accepted 21 April 1999
 |
ABSTRACT |
An unusual Helicobacter sp. was isolated from the blood
of a human immunodeficiency virus (HIV)-infected patient. This organism had spiral morphology, with single amphitrichous flagella, and was
negative for hippurate hydrolysis, production of urease, and reduction
of nitrate. 16S rRNA gene sequence analysis verified that the isolate
was a species of Helicobacter, most closely related to an
undescribed Helicobacter-like isolate from Vancouver,
British Columbia, Canada, and to Helicobacter westmeadii, a
recently described species from Australia. Both organisms had also been
isolated from the blood of HIV-infected patients. These blood isolates, along with Helicobacter cinaedi, form a cluster of closely
related Helicobacter spp. that may represent an emerging
group of pathogens in immunocompromised patients.
 |
TEXT |
Several species of
Helicobacter have been isolated from the blood of
immunocompromised patients. Helicobacter cinaedi and Helicobacter fennelliae are known to cause bacteremia in
human immunodeficiency virus (HIV)-infected patients. More recently, Helicobacter westmeadii (10) and
Helicobacter sp. strain Mainz (3) from
blood cultures of patients with AIDS were described, and there was one
report of Helicobacter sp. strain Mainz in a knee
effusion of an AIDS patient (5). Another
Helicobacter-like organism, Flexispira rappini,
has been isolated from blood but from an otherwise healthy child with
pneumonia (9). Campylobacter spp. have also been
reported to be present in the blood of immunocompromised patients,
especially AIDS patients (6, 7). It is possible that
infections with Helicobacter spp. have occasionally been erroneously attributed to Campylobacter spp. due to their
similar microscopic morphologies. We describe a Helicobacter
isolate (VAH), grown from the blood of an AIDS patient, that may
represent a subgroup within the Helicobacter genus. This
isolate is most closely related to H. westmeadii and another
unnamed Helicobacter sp. (British Columbia Isolate [BCH])
isolated from the blood of an AIDS patient.
Case report.
The patient was a 37-year-old man with advanced
AIDS, schizophrenia, seizures, and end-stage renal disease secondary to
HIV nephropathy. In December 1997, four blood cultures and one stool specimen grew a gram-negative curved rod preliminarily identified as
Campylobacter sp. (not Campylobacter jejuni and
not Campylobacter fetus). The patient initially refused
hospitalization and treatment but by the end of December was placed on
parenteral gentamicin. The organism was not isolated from subsequent
blood or stool cultures. In January 1998, the patient was admitted to
the Veterans Affairs Medical Center with fever, epigastric pain,
vomiting, and worsening diarrhea. Ciprofloxacin and gentamicin therapy
was instituted, but fever and diarrhea persisted. Five days after
admission, the patient suffered a seizure and was transferred to the
intensive care unit, where ciprofloxacin therapy was changed to
ceftriaxone. Transthoracic echocardiography showed multiple
echodense lesions on the mitral valve which were consistent with
endocarditis. The patient stabilized over the next week but then became
hypothermic and hypotensive and was significantly anemic (hematocrit,
17.8%). He had a grand mal seizure followed by cardiopulmonary arrest and could not be resuscitated. No autopsy was obtained. Prior to the
patient's death, a blood culture isolate (VAH) had been sent to the
Microbiology Service at the Clinical Center of the National Institutes
of Health (NIH) for further identification.
Culture and morphologic characteristics.
The organism was
first grown from the patient's blood in aerobic Bactec bottles and
subsequently grew from a stool culture and additional blood cultures.
The stool and blood isolates were the same by colony, Gram stain, and
growth characteristics. VAH was a faintly staining gram-negative,
curved to spiral rod that was best seen by acridine orange staining.
Active motility was observed by dark-field examination of a wet
preparation. Flagella were demonstrated by the Ryu flagellum stain
(Remel Laboratories, Lenexa, Kans.) and by transmission electron
microscopy performed by the Laboratory of Cell and Molecular Structure
(Science Applications International Corp., Frederick, Md.). Ryu stain
showed that most of the cells were amphitrichous with a single
flagellum at each end. Electron microscopy (Fig.
1) showed flagella but no periplasmic fibers. The organism was 3.8 to 4.0 µm long and 0.17 µm wide.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Negatively stained transmission electron micrograph of
VA isolate. Spiral form and single bipolar flagella are evident.
Bar = 0.90 mm.
|
|
Because of its growth on Campylobacter selective medium
(cefoperazone-vancomycin agar), the organism was initially thought to
be a Campylobacter sp., although not C. jejuni
since it was negative for hydrolysis of hippurate. It grew on
cefoperazone-vancomycin agar and chocolate, horse and sheep blood, and
brucella agars but required 5 to 7 days of incubation under
microaerobic conditions at 37°C. It grew best with a Campy-Gen
generator (Oxoid, Basingstoke, England) and less well with Campy-Pak
Plus (Becton Dickinson, Cockeysville, Md.). There was poor growth with
bags filled with Campy Gas (Columbia Diagnostics, Springfield, Va.) and
no growth under standard aerobic conditions, aerobically with 6%
CO2, and anaerobically.
Biochemical characteristics.
Although the organism was urease
negative, it was biochemically more consistent with
Helicobacter than with Campylobacter based on its
failure to hydrolyze hippurate, to reduce nitrate, or to grow at
42°C. A comparison of VAH's biochemical characteristics with those
of other Helicobacter spp. that have been isolated from
humans is presented in Table 1. Except
for lack of sensitivity to cephalothin, the biochemical pattern of VAH
was closest to that of H. fennelliae, a species known to
cause bacteremia and diarrhea in AIDS patients.
Gas chromatography of cellular fatty acids.
Automated fatty
acid methyl ester analysis by gas-liquid chromatography was performed
by Microcheck, Inc. (Northfield, Vt.). The similarity index determined
by comparison of VAH's fatty acid profile with those of reference
strains in Microcheck's database showed an "excellent match" with
H. cinaedi. The Euclidean distance relatedness value between
VAH and H. cinaedi was 8.8, suggestive of a possible species
difference. H. westmeadii was not available for simultaneous
testing; however, VAH showed a significant peak (18:1 w7c) not
described for H. westmeadii (10).
Antibiotic susceptibility testing.
In vitro antibiotic
susceptibilities were determined by the E-test method (AB Biodisk,
Piscataway, N.J.) on chocolate agar incubated in a microaerobic
atmosphere (Campy-Gen). A heavy inoculum was used to ensure sufficient
growth for the plates to be read after 4 days of incubation. Control
organisms were tested with the same media and conditions to validate
that appropriate control MICs were obtained. Since the testing was by a
nonstandardized procedure, these studies were for investigational use
only. The organism was resistant to ciprofloxacin (>32 µg/ml),
erythromycin (>256 µg/ml), trimethoprim-sulfamethoxazole (>2/38
µg/ml), and azithromycin (>256 µg/ml). The MICs determined for
other agents were as follows: clindamycin, 1.5 µg/ml; tetracycline,
0.064 µg/ml; clarithromycin, 1.0 µg/ml; ceftriaxone, 1.5 µg/ml;
and gentamicin, 0.25 µg/ml. Treatment of the patient with the last
two antibiotics likely contributed to his subsequent negative blood cultures.
16S rRNA gene sequencing.
We were unable to identify the
species of VAH based on ultrastructural and biochemical
characteristics, and so 16S rRNA sequence analysis was performed. PCR
of a 1,372-bp region of the 16S rRNA gene was performed in three
segments with primers tailed with M13 sequencing primers, as shown in
Table 2. M13 tailing permitted high-quality direct sequencing of PCR products. Primers were selected based on an alignment of 21 Helicobacter spp. sequences from
GenBank (National Center for Biotechnology Information, Bethesda, Md.). PCR master mix contained 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 10 mM
(each) deoxynucleotides (dATP, dCTP, dGTP, and dTTP), 4 pmol of each
primer, 3 mM MgCl2, 2.5 U of Taq DNA polymerase
(all reagents from Perkin-Elmer, Branchburg, N.J.), and 500 ng of DNA
template in a final volume of 50 ml. Thermocycler conditions were as
follows: 95°C for 4 min; 10 cycles of 95°C for 30 s, 50°C
for 30 s, and 72°C for 1 min; 25 cycles of 95°C for 15 s
and 72°C for 1 min; and 7 min at 72°C. Unincorporated primers and
deoxynucleotides were removed by centrifugal filtration with Millipore
Ultrafree-MC 10,000 NMWL filter units (Millipore, Bedford, Mass.).
Cycle sequencing reactions were performed with M13 forward and reverse
primers (Invitrogen, Carlsbad, Calif.) and the ABI Prism BIGDYE
terminator cycle sequencing ready reaction kit (PE Applied Biosystems,
Foster City, Calif.). Electrophoresis was performed on the ABI PRISM 377 DNA sequencer (PE Applied Biosystems).
Sequences were analyzed with GeneWorks 2.4 nucleic acid and protein
sequence analysis software (IntelliGenetics, Inc., Mountain View,
Calif.). VAH was most closely related (99.3% identity) to BCH, an
unnamed Helicobacter sp. (GenBank accession no. AF023862, BC), obtained from a blood culture of an AIDS patient in Vancouver, Canada (6a). The most closely related named species was
H. westmeadii (99.2% identity), a species isolated from the
blood of AIDS patients in Australia (10). The 16S rRNA gene
sequence of VA showed lower identity, 98.7 and 96%, with H. cinaedi and H. fennelliae, respectively. A phylogenetic
tree was prepared (GeneWorks) with the corresponding 1,372-bp region of
16S rRNA sequences from Helicobacter spp. available from
GenBank (Fig. 2).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Phylogenetic tree delineating the relationship between
the 16S rRNA gene sequence for the VA isolate and sequences available
in GenBank. Scale represents percent homology. Asterisks indicate
species isolated from human blood.
|
|
Discussion.
The nomenclature of Helicobacter has
become more complex as the number of recognized Helicobacter
spp. increases. These species are closely related by 16S rRNA gene
sequence analysis, making specific identification by sequence alone
difficult. DNA-DNA hybridization, which can be used to differentiate
species with high 16S rRNA homology (4), is needed to
definitively identify VAH. H. westmeadii was not available
from the American Type Culture Collection, and we were unsuccessful in
multiple attempts to have it sent from Australia to the NIH. Therefore,
our organism description is limited to our findings of the 16S rRNA
sequence relationships in addition to phenotypic characteristics,
including morphologic, biochemical, and cellular fatty acid properties.
Biochemically, VAH was most similar to H. fennelliae, while
by 16S rRNA sequence analysis, it was more closely related to BCH and
H. westmeadii (Fig. 2). H. westmeadii is curved
to spiral with single polar flagella like VAH, although flagellar
stains of VAH showed most cells to be amphitrichous. A major
biochemical difference between VAH and H. westmeadii is the
inability of VAH to hydrolyze hippurate, reportedly a key feature of
H. westmeadii. Additional differences include those shown in
Table 1, as well as the finding of significant amounts of a cellular
fatty acid peak not reported for H. westmeadii. The
phenotypic and biochemical characteristics of the BC strain were not
available for comparison. Although GC analysis suggested that the VA
isolate is possibly a strain of H. cinaedi, the lack of
nitrate reduction and more importantly a lower rRNA sequence homology
than that found with H. westmeadii (99.2 versus 98.7%) call
this identification into question.
Analysis of 16S rRNA sequence relationships, as shown in the
phylogenetic tree (Fig. 2), shows at least two large groups of Helicobacter spp. The first group contains
Helicobacter pylori and several Helicobacter spp.
that are associated with gastritis in animals, and except for
Helicobacter canis, they exhibit strong urease activity. The
second large group consists of the enteric and blood-associated
Helicobacter spp. including those isolated from blood of
human patients, such as H. fennelliae, H. cinaedi (1), F. rappini (8, 9),
Helicobacter sp. strain Mainz (3), and
H. westmeadii (10). There is a small, more
tightly related cluster (>98% identity) which includes H. cinaedi, H. westmeadii, F. rappini, BCH, and
VAH. This particular cluster represents a subgroup of
Helicobacter causing sepsis primarily in immunocompromised
patients, such as those with AIDS.
H. westmeadii, BC, and VAH were obtained from geographically
distant locations (Australia, western Canada, and eastern United States, respectively). It is possible that this group of blood-borne Helicobacter spp. is more common and widespread than
currently reported since they are difficult to detect in blood cultures and can be misidentified as Campylobacter sp. due to their
curved morphology and positive oxidase and catalase reactions. The
source(s) and incidence, as well as the spectrum of infections with
these organisms, are largely unknown and need further elucidation.
 |
ACKNOWLEDGMENTS |
We thank Caroline Fukuda and the microbiology staff of the Clinical
Pathology Department of the Clinical Center at the NIH for maintaining
the cultures and performing the biochemical tests. We also thank Kunio
Nagashima of Laboratory of Cell and Molecular Structure (Science
Applications International Corp. Frederick, Frederick, Md.) for the
electron microscopy and Eric Konieczynski of the National Cancer
Institute for running the sequencing gels.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Microbiology
Service, Clinical Pathology Department, Building 10, Room 2C-385, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 496-4433. Fax: (301)
402-1886. E-mail: vgill{at}nih.gov.
 |
REFERENCES |
| 1.
|
Burman, W. J.,
D. L. Cohn,
R. R. Reves, and M. L. Wilson.
1995.
Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia.
Clin. Infect. Dis.
20:564-570[Medline].
|
| 2.
|
Eaton, K. A.,
F. E. Dewhirst,
M. J. Radin,
J. G. Fox,
B. J. Paster,
S. Krakowka, and D. R. Morgan.
1993.
Helicobacter acinonyx sp. nov., isolated from cheetahs with gastritis.
Int. J. Syst. Bacteriol.
43:99-106[Abstract/Free Full Text].
|
| 3.
|
Fleisch, F.,
A. Burnens,
R. Weber, and R. Zbinden.
1998.
Helicobacter species strain Mainz isolated from cultures of blood and from two patients with AIDS.
Clin. Infect. Dis.
26:526-527[Medline].
|
| 4.
|
Fox, G. E.,
J. D. Wisotzkey, and P. Jurtshuk, Jr.
1992.
How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity.
Int. J. Syst. Bacteriol.
42:166-170[Abstract/Free Full Text].
|
| 5.
|
Husmann, M.,
C. Gries,
P. Jehnichen,
T. Woelfel,
G. Gerken,
W. Ludwig, and S. Bhakdi.
1994.
Helicobacter sp. strain Mainz isolated from an AIDS patient with septic arthritis: case report and nonradioactive analysis of 16S rRNA sequence.
J. Clin. Microbiol.
32:3037-3039[Abstract/Free Full Text].
|
| 6.
|
Molina, J. M.,
I. Casin,
P. Hausfater,
E. Giretti,
Y. Welker,
J. M. Decazes,
V. Garrait,
P. LaGrange, and A. Modai.
1995.
Campylobacter infections in HIV-infected patients clinical and bacteriological features.
AIDS
9:881-885[Medline].
|
| 6a.
| Morshed, M. G., et al. 1997. Unpublished data.
|
| 7.
|
Pigraou, C.,
R. Bartolome,
B. Almirante,
A. M. Planes,
J. Gavalda, and A. Pahissa.
1997.
Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.
Clin. Infect. Dis.
25:1414-1420[Medline].
|
| 8.
|
Schauer, D. B.,
N. Ghori, and S. Falkow.
1993.
Isolation and characterization of "Flexispira rappini" from laboratory mice.
J. Clin. Microbiol.
31:2709-2714[Abstract/Free Full Text].
|
| 9.
|
Tee, W.,
K. Leder,
E. Karroum, and M. Dyall-Smith.
1998.
"Flexispira rappini" bacteremia in a child with pneumonia.
J. Clin. Microbiol.
36:1679-1682[Abstract/Free Full Text].
|
| 10.
|
Trivett-Moore, N. L.,
W. D. Rawlinson,
M. Yuen, and G. L. Gilbert.
1997.
Helicobacter westmeadii sp. nov., a new species isolated from blood cultures of two AIDS patients.
J. Clin. Microbiol.
35:1144-1150[Abstract].
|
Journal of Clinical Microbiology, August 1999, p. 2729-2733, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Iwashita, H., Fujii, S., Kawamura, Y., Okamoto, T., Sawa, T., Masaki, T., Nishizono, A., Higashi, S., Kitamura, T., Tamura, F., Sasaki, Y., Akaike, T.
(2008). Identification of the Major Antigenic Protein of Helicobacter cinaedi and Its Immunogenicity in Humans with H. cinaedi Infections. CVI
15: 513-521
[Abstract]
[Full Text]
-
Harris, K. A., Fidler, K. J., Hartley, J. C., Vogt, J., Klein, N. J., Monsell, F., Novelli, V. M.
(2002). Unique Case of Helicobacter sp. Osteomyelitis in an Immunocompetent Child Diagnosed by Broad-Range 16S PCR. J. Clin. Microbiol.
40: 3100-3103
[Abstract]
[Full Text]
-
Fernandez, K. R., Hansen, L. M., Vandamme, P., Beaman, B. L., Solnick, J. V.
(2002). Captive Rhesus Monkeys (Macaca mulatta) Are Commonly Infected with Helicobacter cinaedi. J. Clin. Microbiol.
40: 1908-1912
[Abstract]
[Full Text]
-
Solnick, J. V., Schauer, D. B.
(2001). Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases. Clin. Microbiol. Rev.
14: 59-97
[Abstract]
[Full Text]
-
Tee, W., Hinds, S., Montgomery, J., Dyall-Smith, M. L.
(2000). A Probable New Helicobacter Species Isolated from a Patient with Bacteremia. J. Clin. Microbiol.
38: 3846-3848
[Abstract]
[Full Text]
-
Han, S.-R., Schindel, C., Genitsariotis, R., Märker-Hermann, E., Bhakdi, S., Maeurer, M. J.
(2000). Identification of a Unique Helicobacter Species by 16S rRNA Gene Analysis in an Abdominal Abscess from a Patient with X-Linked Hypogammaglobulinemia. J. Clin. Microbiol.
38: 2740-2742
[Abstract]
[Full Text]
-
Vandamme, P., Harrington, C. S., Jalava, K., On, S. L. W.
(2000). Misidentifying Helicobacters: the Helicobacter cinaedi Example. J. Clin. Microbiol.
38: 2261-2266
[Abstract]
[Full Text]